David Friend serves as the Vice President of Global Revenue at Inato, where he leverages over 25 years of extensive experience in healthcare and clinical research to drive transformative growth in the clinical trial landscape. His unique blend of expertise spans clinical laboratory operations, clinical...
David Friend serves as the Vice President of Global Revenue at Inato, where he leverages over 25 years of extensive experience in healthcare and clinical research to drive transformative growth in the clinical trial landscape. His unique blend of expertise spans clinical laboratory operations, clinical research, and eClinical sales, making him a pivotal figure in advancing Inato's mission to democratize access to clinical trials. Under his leadership, Inato is developing the world’s first clinical trial marketplace, which aims to enhance visibility and engagement among a diverse population of healthcare providers and patients.
David’s role involves not only spearheading revenue generation strategies but also fostering collaborations that bridge the gap between pharmaceutical companies, medical device manufacturers, and clinical sites. His deep understanding of clinical trials, particularly in oncology and biotechnology, positions him as a key player in optimizing trial designs and implementation processes. He is adept at navigating the complexities of regulatory compliance, including 21 CFR Part 11, ensuring that all clinical data management practices meet stringent validation standards.
Key projects under David's guidance include initiatives aimed at expanding Inato's footprint in underserved markets, thereby increasing patient diversity in clinical trials. His commitment to revenue and profit growth is complemented by a passion for improving patient outcomes, making him a respected leader in the industry. As Inato continues to innovate and reshape the clinical trial ecosystem, David Friend's strategic vision and operational expertise remain instrumental in driving the company’s success and fulfilling its mission to bring clinical research to every patient, regardless of their background or location.
